Klencke Barbara

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 11% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Klencke Barbara's trades of TScan Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
364.81
Quantity 85,261 +37.9%
Value US$4,129,112
Transaction date
Purchase
Price
48.62
Quantity 78,025 +49.1%
Value US$2,084,747
Transaction date
Purchase
Price
391.18
Quantity 99,519 +11.7%
Value US$4,374,677
Transaction date
Purchase
Price
5.08
Quantity 5,000 +20.0%
Value US$25,400
Transaction date
Purchase
Price
12.25
Quantity 3,325 +198.5%
Value US$40,738
Transaction date
Purchase
Price
12.22
Quantity 5,950 +146.9%
Value US$72,710
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-24 2024-09-23
B Purchase
85,261 +37.9%
364.81
US$4,129,112 		85,261 +37.9% 364.81 US$4,129,112
2024-08-27 2024-08-26
B Purchase
78,025 +49.1%
48.62
US$2,084,747 		78,025 +49.1% 48.62 US$2,084,747
2024-08-27 2024-08-23
B Purchase
99,519 +11.7%
391.18
US$4,374,677 		99,519 +11.7% 391.18 US$4,374,677
2023-12-18 2023-12-14
B Purchase
5,000 +20.0%
5.08
US$25,400 		5,000 +20.0% 5.08 US$25,400
2020-08-18 2020-08-18
B Purchase
3,325 +198.5%
12.25
US$40,738 		3,325 +198.5% 12.25 US$40,738
2020-08-18 2020-08-18
B Purchase
5,950 +146.9%
12.22
US$72,710 		5,950 +146.9% 12.22 US$72,710